TerrAscend (TSNDF) Profit After Tax (2021 - 2026)
TerrAscend's (TSNDF) quarterly Profit After Tax came in at -$7.7 million in Q1 2026, up 37.22% year-on-year from -$5.6 million in Q1 2025, and down 325.47% on a QoQ basis from $3.4 million in Q4 2025.
TerrAscend (TSNDF) Profit After Tax (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Profit After Tax data on file, last reported at -$7.7 million in Q1 2026.
- On a quarterly basis, Profit After Tax rose 37.22% year-over-year to -$7.7 million in Q1 2026; TTM through Mar 2026 was -$62.3 million, a 228.48% decrease from a year earlier, with the FY2025 full-year figure at -$82.4 million, down 294.22% from the prior year.
- Profit After Tax for Q1 2026 stood at -$7.7 million, down from $3.4 million in the prior quarter.
- Over the last five years, Profit After Tax for TSNDF reached as high as $22.8 million in Q4 2024 and fell as low as -$300.6 million in Q3 2022.
- Historically, Profit After Tax has averaged -$27.9 million across 5 years, with a median of -$12.3 million in 2025.
- Across the five-year window, Profit After Tax soared 2306.27% in 2022 and sank 671.32% in 2025, its largest moves.
- Year by year, Profit After Tax stood at $13.4 million in 2022, then sank by 446.64% to -$46.5 million in 2023, then surged by 149.05% to $22.8 million in 2024, then sank by 85.04% to $3.4 million in 2025, then tumbled by 325.47% to -$7.7 million in 2026.
- Per Business Quant data, the three most recent Profit After Tax figures were -$7.7 million in Q1 2026, $3.4 million in Q4 2025, and -$9.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 369.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.35 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn | -7.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.70 Mn |
| Dec 31, 2025 | 3.42 Mn |
| Sep 30, 2025 | -9.91 Mn |
| Jun 30, 2025 | -48.11 Mn |
| Mar 31, 2025 | -12.27 Mn |
| Dec 31, 2024 | 22.83 Mn |
| Sep 30, 2024 | -23.29 Mn |
| Jun 30, 2024 | -6.24 Mn |
| Mar 31, 2024 | -14.85 Mn |
| Dec 31, 2023 | -46.54 Mn |
| Sep 30, 2023 | -8.44 Mn |
| Jun 30, 2023 | -13.48 Mn |
| Mar 31, 2023 | -22.77 Mn |
| Dec 31, 2022 | 13.43 Mn |
| Sep 30, 2022 | -300.56 Mn |
| Jun 30, 2022 | 14.16 Mn |
| Mar 31, 2022 | -13.75 Mn |
| Dec 31, 2021 | 558,000.00 |
| Sep 30, 2021 | 54.43 Mn |
| Jun 30, 2021 | -30.66 Mn |